Connection

Fengcai Zhu to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Fengcai Zhu has written about Clinical Trials, Phase III as Topic.
Fengcai Zhu
Connection Strength
0.161
Clinical Trials, Phase III as Topic
  1. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need. Signal Transduct Target Ther. 2021 02 02; 6(1):48.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.